Anzeige
Mehr »
Montag, 27.04.2026 - Börsentäglich über 12.000 News
Der AI-Boom braucht günstigen Strom - Diese Aktie hat ihn
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Sharecast

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
13:23Retail sales hit by 'fragile' consumer confidence - CBI
13:23London midday: FTSE edges up as Iran said to have made peace proposal to US
13:23Power Metal environmental plan for Tati Gold Project approved
12:53Canaccord Genuity lowers target price on Bango
12:53Gana Media shares jump on new betting partnership in Mexico
12:23China orders Meta to unwind $2bn acquisition of AI firm Manus
12:23Entain tumbles as shareholder Eminence Capital to be shuttered
12:23Vanquis accepts FCA's motor finance redress scheme
12:23Asia report: Markets mostly rise despite lack of US-Iran peace progress
11:53Goldman double downgrades Sainsbury's to 'sell', shares slump
11:53PensionBee reaches £8bn AUA milestone
11:23China industrial profits post sharp jump in March
10:53Power Probe gives upbeat outlook as FY revenues climb
10:53Christie Group hikes dividend as FY profits, revenues jump
10:23Consumer sentiment weakens sharply in Germany
10:23Harworth wins planning approval for Microsoft data centre scheme
10:23Whitbread planning £1.5bn hotel selloff - report
09:53Europe open: Shares mixed, oil up as Iran war talks continue to stall
09:53London open: FTSE flat, oil rises as US-Iran peace talks stall
09:53AstraZeneca's Saphnelo Pen gets green light from US FDA
09:23Intertek slumps after rejecting improved takeover proposal from EQT
09:23US court rules against GSK in dispute with AnaptysBio
09:23Molten Ventures sees sharp jump in annual GPV, NAV
08:53Iran said to have given US proposal for reopening Hormuz, ending war
08:53Molten Ventures expects to report 'sharp rise' in both NAV and GPV, AstraZeneca's Saphnelo receives US FDA approval